- Home
- EDIT vs FAT Comparison
EDIT vs FAT Comparison
Compare EDIT & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- FAT
- Stock Information
- Founded
- EDIT 2013
- FAT 2017
- Country
- EDIT United States
- FAT United States
- Employees
- EDIT N/A
- FAT N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- FAT Restaurants
- Sector
- EDIT Health Care
- FAT Consumer Discretionary
- Exchange
- EDIT Nasdaq
- FAT Nasdaq
- Market Cap
- EDIT 99.9M
- FAT 94.4M
- IPO Year
- EDIT 2016
- FAT 2017
- Fundamental
- Price
- EDIT $1.21
- FAT $5.64
- Analyst Decision
- EDIT Buy
- FAT
- Analyst Count
- EDIT 14
- FAT 0
- Target Price
- EDIT $8.08
- FAT N/A
- AVG Volume (30 Days)
- EDIT 2.7M
- FAT 22.4K
- Earning Date
- EDIT 02-26-2025
- FAT 03-06-2025
- Dividend Yield
- EDIT N/A
- FAT 10.01%
- EPS Growth
- EDIT N/A
- FAT N/A
- EPS
- EDIT N/A
- FAT N/A
- Revenue
- EDIT $61,759,000.00
- FAT $606,008,000.00
- Revenue This Year
- EDIT N/A
- FAT $27.15
- Revenue Next Year
- EDIT N/A
- FAT $10.38
- P/E Ratio
- EDIT N/A
- FAT N/A
- Revenue Growth
- EDIT 150.95
- FAT 42.38
- 52 Week Low
- EDIT $1.12
- FAT $4.51
- 52 Week High
- EDIT $11.58
- FAT $9.48
- Technical
- Relative Strength Index (RSI)
- EDIT 34.86
- FAT 65.25
- Support Level
- EDIT $1.15
- FAT $5.22
- Resistance Level
- EDIT $1.27
- FAT $5.65
- Average True Range (ATR)
- EDIT 0.10
- FAT 0.15
- MACD
- EDIT 0.04
- FAT 0.03
- Stochastic Oscillator
- EDIT 21.11
- FAT 95.83
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About FAT FAT Brands Inc.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.